Fundies.
English

Kiniksa Pharmaceuticals International, plc

EDGAR
KNSA Quarterly report (10-Q) · filed 2026-10-27

Annual consolidated revenue for 2025: about Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 677.6M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 423.2M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

286 million Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA

2026 Q3 · Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA

Exact inputs and evidence
  • Revenue: 285970000 Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA Source

Operating margin

18.97%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: 54236000 Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA Source
  • Revenue: 285970000 Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA Source
Cash and cash equivalents
81.7 million Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA Source
Exact value

81660000 Unit_Standard_USD_e0LQa9Mj3EKNg5OknWR7SA

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 3 of 11 periods available· newest 2025-12-31
  • Net income: 3 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +60.1%

    Prior period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 423.24 million

    –

    Current period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 677.56 million

    –

    Exact inputs and evidence

    677564000 − 423239000 = 254325000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

    423239000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    677564000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 102.2 million

    Prior period

    −Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 43.19 million

    –

    Current period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 59.01 million

    –

    Exact inputs and evidence

    59005000 − -43193000 = 102198000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

    -43193000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    59005000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +437.1%

    Prior period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 25.69 million

    –

    Current period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 137.99 million

    –

    Exact inputs and evidence

    137985000 − 25689000 = 112296000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

    25689000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    137985000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +466.1%

    Prior period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 277,000

    –

    Current period

    Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 1.57 million

    –

    Exact inputs and evidence

    1568000 − 277000 = 1291000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

    277000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1568000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 677.56 million 100% of revenue
  • Cost of revenue Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 77.67 million 11% of revenue
  • Operating expenses Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 293.13 million 43% of revenue
  • Other operating costs Derived Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 229.55 million 34% of revenue
  • Operating income Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 77.22 million 11% of revenue
  • Tax, interest and other Derived Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 18.22 million 2.7% of revenue
  • Net income Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 59.01 million 8.7% of revenue

Cash

  • Operating cash flow Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 137.99 million 20% of revenue
  • Capital expenditure Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 1.57 million 0.2% of revenue
  • Free cash flow Derived Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 136.42 million 20% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Operating loss: operating costs were 109% of revenue.
  • 2024 Operating loss: operating costs were 111% of revenue.
  • 2025 89%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-31270259000 295455000 Derived -25196000 -39280000 Derived 14084000 13171000 Derived
Source
2024 2024-01-01 – 2024-12-31423239000 468855000 Derived -45616000 -2423000 Derived -43193000 25412000 Derived
Source
2025 2025-01-01 – 2025-12-31677564000 600343000 Derived 77221000 18216000 Derived 59005000 136417000 Derived
Source

Amounts are exact, in Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 677.6M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.731.8M548.8M365.9M182.9M0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg)Source evidence
2023Revenue270259000
2024Revenue423239000
2025Revenue677564000

Revenue growth

Change in revenue from the same financial period one year earlier.

60.1% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.65%49%32%16%0%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year56.6%
2025Year over year60.1%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 11.4% 2025
Net margin 8.7% 2025
Free cash flow margin 20.1% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.22.6%13.6%4.7%-4.3%-13.3%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-9.3%
2024Operating margin-10.8%
2025Operating margin11.4%
2023Net margin5.2%
2024Net margin-10.2%
2025Net margin8.7%
2023Free cash flow margin4.9%
2024Free cash flow margin6%
2025Free cash flow margin20.1%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 138M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.149.0M111.8M74.5M37.3M0.0202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg)Source evidence
2023Operating cash flow13301000
2024Operating cash flow25689000
2025Operating cash flow137985000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 136.4M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.147.3M110.5M73.7M36.8M0.0202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg)Source evidence
2023Free cash flow13171000
2024Free cash flow25412000
2025Free cash flow136417000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Liabilities / assetsNot reportedNo source recorded
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 14.08 million
Exact value

Exact value: 14084000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2023-01-01 – 2023-12-31: 14084000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 13.3 million
Exact value

Exact value: 13301000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2023-01-01 – 2023-12-31: 13301000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 130,000
Exact value

Exact value: 130000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2023-01-01 – 2023-12-31: 130000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 13.17 million
Calculation and evidence

13301000 − 130000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Exact free cash flow: 13171000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 43.19 million
Exact value

Exact value: -43193000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2024-01-01 – 2024-12-31: -43193000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 25.69 million
Exact value

Exact value: 25689000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2024-01-01 – 2024-12-31: 25689000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 277,000
Exact value

Exact value: 277000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2024-01-01 – 2024-12-31: 277000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 25.41 million
Calculation and evidence

25689000 − 277000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Exact free cash flow: 25412000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 59.01 million
Exact value

Exact value: 59005000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2025-01-01 – 2025-12-31: 59005000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 137.99 million
Exact value

Exact value: 137985000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2025-01-01 – 2025-12-31: 137985000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 1.57 million
Exact value

Exact value: 1568000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

2025-01-01 – 2025-12-31: 1568000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg 136.42 million
Calculation and evidence

137985000 − 1568000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Exact free cash flow: 136417000 Unit_Standard_USD_MyS3OudFO0SwNWl9bsCgPg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 4,771 latest values · 4,771 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001730430, 1730430, KNSA, edgar:1730430

Also known as Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals, Ltd., Kiniksa Pharmaceuticals, Ltd.